Company Filing History:
Years Active: 2001
Title: N Jan Chalupny: Innovator in Immunomodulation
Introduction
N Jan Chalupny is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of immunology, particularly through her innovative approaches to immunomodulation. Her work has the potential to impact cancer therapy and immunosuppression significantly.
Latest Patents
N Jan Chalupny holds a patent titled "Methods and compositions for immunomodulation." This patent reveals the unexpected result that two anti-4-1BB monoclonal antibodies can inhibit both primary and secondary humoral responses to at least T-cell dependent antigens in vivo. Such antibodies provide a novel approach to immunosuppression and cancer therapy in vivo.
Career Highlights
Chalupny is currently associated with Bristol-Myers Squibb Company, where she continues to advance her research and development efforts. Her work at this leading biopharmaceutical company allows her to collaborate with other experts in the field and contribute to groundbreaking innovations.
Collaborations
One of her notable coworkers is Alejandro A Aruffo, with whom she has likely collaborated on various projects related to immunology and therapeutic development.
Conclusion
N Jan Chalupny's contributions to immunomodulation and her innovative patent work highlight her as a key figure in the field of immunology. Her ongoing research at Bristol-Myers Squibb Company continues to pave the way for advancements in cancer therapy and immunosuppression.